Annual report pursuant to Section 13 and 15(d)

Consolidated Statements Of Changes In Stockholders' Equity

v3.8.0.1
Consolidated Statements Of Changes In Stockholders' Equity - USD ($)
Preferred Stock
Common Stock [Member]
Additional Paid-In Capital [Member]
Accumulated Deficit [Member]
Other Comprehensive Income / Loss
Treasury Stock
Total
Beginning balance, shares at Dec. 31, 2015   4,909,686          
Beginning balance, value at Dec. 31, 2015   $ 4,909 $ 99,763,101 $ (88,131,899) $ 253,734 $ (5,281,180) $ 6,608,665
Issuance of common stock to vendors, shares   253,630          
Issuance of common stock to vendors, value   $ 254 1,174,383       1,174,637
Exchange of common stock for Series A preferred stock, shares 970,000 (970,000)          
Exchange of common stock for Series A preferred stock, value $ 970 $ (970)          
Warrant expense     1,121,466       1,121,466
Issuance of warrants in connection with debt (net of issuance costs of $16,769)     2,069,673       2,069,673
Conversion of notes, shares issued   1,313,132          
Conversion of notes, value   $ 1,313 12,014,887       12,016,200
Settlement of accrued interest in common stock   $ 60 237,184       237,244
Settlement of accrued interest in common stock, shares   59,904          
Issuance of common stock in connection with completion of asset acquisition, shares   3,045,455          
Issuance of common stock in connection with completion of asset acquisition, value   $ 3,045 34,899,399       34,902,444
Issuance of warrants in connection with completion of asset acquisition     853,039       853,039
Issuance of Series B preferred stock in public offering, shares 2,424,242            
Issuance of Series B preferred stock in public offering, value $ 2,424   5,703,577       5,706,001
Issuance of warrants in public offering     3,763,997       3,763,997
Record beneficial conversion feature in connection with public offering     4,035,260       4,035,260
Acrete beneficial conversion feature in connection with public offering     (4,035,260)       (4,035,260)
Conversion of Series B preferred stock to shares of common stock, Shares (118,500) 118,500          
Conversion of Series B preferred stock to shares of common stock, Value $ (119) $ 119          
Share-based payments     1,922,215       1,922,215
Adjust shares in connection with reverse merger and reverse split   722          
Net loss       (54,206,106)     (54,206,106)
Ending balance, shares at Dec. 31, 2016 3,275,742 8,731,029          
Ending balance, value at Dec. 31, 2016 $ 3,275 $ 8,730 163,522,921 (142,338,005) 253,734 (5,281,180) 16,169,475
Warrant expense     (126,316)       (126,316)
Conversion of notes, shares issued   125,397          
Conversion of notes, value   $ 125 (125)        
Conversion of Series B preferred stock to shares of common stock, Shares (185,000) 185,000          
Conversion of Series B preferred stock to shares of common stock, Value $ (185) $ 185          
Share-based payments     1,784,129       1,784,129
Common stock awards to vendors     69,303       69,303
Net loss       (3,595,132)     (3,595,132)
Ending balance, shares at Dec. 31, 2017 3,090,742 9,041,426          
Ending balance, value at Dec. 31, 2017 $ 3,090 $ 9,040 $ 165,249,912 $ (145,933,137) $ 253,734 $ (5,281,180) $ 14,301,459